There is no consensus regarding the secondary cytoreduction surgery (CRS) in recurrent ovarian cancer patients. The present study aims to determine the value of secondary CRS and the eligible subgroup for this procedure.
Methods:
96 platinum-sensitive recurrent ovarian cancer patients were…
Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
No comments:
Post a Comment